chr5-172334433-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001017995.3(SH3PXD2B):c.*3936G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.057 in 987,876 control chromosomes in the GnomAD database, including 1,794 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.040 ( 190 hom., cov: 33)
Exomes 𝑓: 0.060 ( 1604 hom. )
Consequence
SH3PXD2B
NM_001017995.3 3_prime_UTR
NM_001017995.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.919
Genes affected
SH3PXD2B (HGNC:29242): (SH3 and PX domains 2B) This gene encodes an adapter protein that is characterized by a PX domain and four Src homology 3 domains. The encoded protein is required for podosome formation and is involved in cell adhesion and migration of numerous cell types. Mutations in this gene are the cause of Frank-ter Haar syndrome (FTHS), and also Borrone Dermato-Cardio-Skeletal (BDCS) syndrome. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 5-172334433-C-T is Benign according to our data. Variant chr5-172334433-C-T is described in ClinVar as [Benign]. Clinvar id is 352739.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0598 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SH3PXD2B | NM_001017995.3 | c.*3936G>A | 3_prime_UTR_variant | 13/13 | ENST00000311601.6 | NP_001017995.1 | ||
SH3PXD2B | XM_017009351.2 | c.*3936G>A | 3_prime_UTR_variant | 14/14 | XP_016864840.1 | |||
SH3PXD2B | NM_001308175.2 | c.1189-9053G>A | intron_variant | NP_001295104.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SH3PXD2B | ENST00000311601.6 | c.*3936G>A | 3_prime_UTR_variant | 13/13 | 1 | NM_001017995.3 | ENSP00000309714 | P1 | ||
SH3PXD2B | ENST00000519643.5 | c.1189-9053G>A | intron_variant | 1 | ENSP00000430890 | |||||
SH3PXD2B | ENST00000518522.5 | c.201-664G>A | intron_variant | 5 | ENSP00000428076 | |||||
SH3PXD2B | ENST00000636523.1 | c.1229-9053G>A | intron_variant | 5 | ENSP00000490082 |
Frequencies
GnomAD3 genomes AF: 0.0405 AC: 6167AN: 152206Hom.: 190 Cov.: 33
GnomAD3 genomes
AF:
AC:
6167
AN:
152206
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0600 AC: 50105AN: 835552Hom.: 1604 Cov.: 32 AF XY: 0.0600 AC XY: 23152AN XY: 385996
GnomAD4 exome
AF:
AC:
50105
AN:
835552
Hom.:
Cov.:
32
AF XY:
AC XY:
23152
AN XY:
385996
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0405 AC: 6163AN: 152324Hom.: 190 Cov.: 33 AF XY: 0.0392 AC XY: 2917AN XY: 74480
GnomAD4 genome
AF:
AC:
6163
AN:
152324
Hom.:
Cov.:
33
AF XY:
AC XY:
2917
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
67
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Frank-Ter Haar syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at